Medicines and Healthcare Products Regulatory Agency (Health) [2022] UKICO 118690 (15 August 2022)


BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?

No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!



BAILII [Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback]

Information Commissioner's Office
You are here: BAILII >> Databases >> Information Commissioner's Office >> Medicines and Healthcare Products Regulatory Agency (Health) [2022] UKICO 118690 (15 August 2022)
URL: http://www.bailii.org/uk/cases/UKICO/2022/118690.html
Cite as: [2022] UKICO 118690

[New search] [Printable PDF version] [Help]

Medicines and Healthcare Products Regulatory Agency

The complainant has requested the names of licenced importers of co-proxamol over a 10 year period. The Medicines and Healthcare products Regulatory Agency (MHRA) withheld the information under section 43(2) of FOIA, which concerns commercial interests. MHRA subsequently confirmed that it is also relying in section 41(1) of FOIA to withhold the information, as it considers it to be information provided to MHRA in confidence. The Commissioner’s decision is as follows: The withheld information does not engage the exemptions under section 41(1) or 43(2) of FOIA. The Commissioner requires MHRA to take the following step to ensure compliance with the legislation: Disclose to the complainant the information it is withholding under the above two exemptions.

FOI 43: Complaint upheld FOI 41: Complaint upheld

Decision notice: 118690

BAILII: Copyright Policy | Disclaimers | Privacy Policy | Feedback | Donate to BAILII
URL: http://www.bailii.org/uk/cases/UKICO/2022/118690.html